Citizens (CIA) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Income before federal income tax rose to $2.4 million for Q1 2026 from a loss of $1.8 million in Q1 2025, mainly due to a $3.9 million improvement in investment-related gains and losses, reflecting the absence of a prior-year BlackRock write-down.
Total revenues reached $59.7 million in Q1 2026, a 7% increase year-over-year from $55.7 million.
Net income was $2.3 million, reversing a $1.6 million loss in Q1 2025.
Book value per share of Class A common stock was $4.74, with an adjusted book value of $6.48.
Fourteen consecutive quarters of year-over-year growth in first year premiums.
Financial highlights
Total revenues increased to $59.7 million in Q1 2026 from $55.7 million in Q1 2025, driven by higher investment gains.
Net income for Q1 2026 was $2.3 million, compared to a net loss of $1.6 million in Q1 2025.
Diluted EPS was $0.04 for Q1 2026, up from a loss of $0.03 per share in Q1 2025.
Net investment income slightly decreased to $17.3 million from $17.4 million year-over-year, with annualized yield on average invested assets at 4.54%.
Investment-related gains were $1.0 million in Q1 2026 versus losses of $2.9 million in Q1 2025.
Outlook and guidance
Expectation of continued growth in Domestic Insurance segment and ongoing shift in International Insurance product mix toward whole life products.
Management expects continued revenue and profit growth for full year 2026.
Net investment income anticipated to increase as new investments in private placement credit are made.
Maturity benefits from endowment products expected to decrease throughout 2026, improving cash from operations.
Long-term EPS expansion anticipated through revenue growth and operating leverage.
Latest events from Citizens
- Shareholders will vote on directors, auditor, executive pay, and a major incentive plan update.CIA
Proxy filing30 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.CIA
Proxy filing30 Apr 2026 - Record 2025 revenues and insurance in force set the stage for accelerating EPS growth.CIA
Investor presentation15 Apr 2026 - Record revenues and unique white label growth position the company for continued expansion in 2026.CIA
Emerging Growth Conference 912 Apr 2026 - Record 2025 revenues and insurance in force, with strong premium growth and positive 2026 outlook.CIA
Q4 202512 Mar 2026 - Strong growth, record sales, and expanding market presence drive optimism for future performance.CIA
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Rapid growth, global expansion, and conservative management drive strong performance.CIA
Emerging Growth Virtual Conference19 Dec 2025 - Up to 5,000,000 shares offered via a direct investment plan for long-term capital needs.CIA
Registration Filing16 Dec 2025 - Rapid growth, innovation, and balanced global expansion drive the company's forward strategy.CIA
Emerging Growth Conference 8812 Dec 2025